Genetic analyses of patients with t(8;21) AML and extensive animal modelling of the haematopoietic effects of the AML1-ETO translocation have identified that AML1-ETO is expressed in early HSCs and increases self-renewal but is not sufficient for leukemogenesis alone20, 21, 22. This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.